CIXUTUMUMAB: 26 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
26
Total FAERS Reports
8 (30.8%)
Deaths Reported
11
Hospitalizations
26
As Primary/Secondary Suspect
3
Life-Threatening
First Report: 20101226 · Latest Report: 20130625
What Are the Most Common CIXUTUMUMAB Side Effects?
#1 Most Reported
Acute myeloid leukaemia
7 reports (26.9%)
#2 Most Reported
Fatigue
6 reports (23.1%)
#3 Most Reported
Dehydration
6 reports (23.1%)
All CIXUTUMUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute myeloid leukaemia | 7 | 26.9% | 7 | 0 |
| Dehydration | 6 | 23.1% | 0 | 5 |
| Fatigue | 6 | 23.1% | 0 | 5 |
| Drug ineffective | 5 | 19.2% | 3 | 0 |
| Dyspnoea | 5 | 19.2% | 0 | 5 |
| Muscular weakness | 5 | 19.2% | 0 | 5 |
| Neutrophil count decreased | 5 | 19.2% | 0 | 5 |
Who Reports CIXUTUMUMAB Side Effects? Age & Gender Data
Gender: 76.5% female, 23.5% male. Average age: 53.2 years. Most reports from: US. View detailed demographics →
Is CIXUTUMUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 2 | 0 | 2 |
| 2011 | 7 | 0 | 7 |
| 2013 | 2 | 0 | 2 |
What Is CIXUTUMUMAB Used For?
| Indication | Reports |
|---|---|
| Rhabdomyosarcoma | 9 |
| Small cell lung cancer | 6 |
Official FDA Label for CIXUTUMUMAB
Official prescribing information from the FDA-approved drug label.